Pricing Log in Create free account

Arrowhead Pharmaceuticals, Inc. (ARWR) vs Twist Bioscience Corporation (TWST)

Arrowhead Pharmaceuticals, Inc. and Twist Bioscience Corporation are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Twist Bioscience Corporation are of similar size ($8.1B and $7.9B). Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 16.1%. Twist Bioscience Corporation has the higher net margin (−31.7% vs −47.8%) and the lower return on invested capital (−30.8% vs 0.00%). Across the 18 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 11 and Twist Bioscience Corporation on 7.

Valuation

Metric ARWR TWST Biotechnology median
P/E n/m n/m 10.26
P/S 12.34 17.60 9.18
P/B 17.73 17.05 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 11.24 17.25 8.98
Earnings yield (3.90%) (1.82%) (34.89%)
Free cash flow yield (0.91%) (1.26%) (24.52%)

Profitability

Metric ARWR TWST Biotechnology median
Gross margin 100.00% 51.97% 65.16%
Operating margin (33.82%) (33.58%) 0.00%
Net margin (47.79%) (31.66%) 0.00%
Free cash flow margin (11.22%) (22.15%) 0.00%
Return on equity (64.91%) (29.59%) (50.12%)
Return on assets (18.32%) (20.78%) (45.60%)
Return on invested capital 0.00% (30.83%) 0.00%

Growth

Metric ARWR TWST Biotechnology median
Revenue growth (TTM) 16.13% 19.19% 6.26%
EPS growth (last fiscal year) 99.80% 63.89% 29.88%
Revenue growth, 5-year CAGR 56.63% 33.11% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARWR TWST Biotechnology median
Debt to equity 1.85 0.03 0.00
Current ratio 5.90 2.67 4.89
Net debt to EBITDA (5.70) 1.95 1.01

Dividend

Metric ARWR TWST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARWR TWST Biotechnology median
Market cap 8.12b 7.94b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack